GEN Exclusives

More »

GEN News Highlights

More »
Nov 25, 2009

iThemba Pharmaceuticals and Pyxis Discovery to Commingle Service Offerings

  • iThemba Pharmaceuticals' service division and Pyxis Discovery signed a collaborative agreement to jointly market each other’s services. Pyxis' computational chemistry and lead discovery expertise will be coupled with iThemba's service division to provide medicinal and synthetic chemistry support to projects identified through Pyxis' international client network.

    iThemba Pharmaceuticals and Pyxis Discovery also inked a co-marketing agreement to offer virtual libraries that will be exclusively synthesized for clients.

    iThemba Pharmaceuticals, which is based in South Africa, was founded to discover and develop new and affordable medicines for the diseases of poverty in Africa. The company is funded by the Biotechnology Regional Innovation Centers, LIFElab, and BioPAD of the Department of Science and Technology, Government of South Africa.



Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

Be sure to take the GEN Poll

Tackling the Global Problem of Fake Medicines

Policy proposals to address the growing global problem of fake medicines include a global agreement, similar to the Framework Convention on Tobacco Control, and stricter national laws to prosecute those who knowingly sell counterfeit medicines. Do you think these steps will be successful?

More »